- Home
- MDCX vs MMA Comparison
MDCX vs MMA Comparison
Compare MDCX & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | MDCX | MMA |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | Australia |
| Employees | 12 | 22 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 11.8M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | MDCX | MMA |
|---|---|---|
| Price | $0.40 | $0.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $23.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 316.8K |
| Earning Date | 05-11-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.37 | $0.35 |
| 52 Week High | $8.90 | $2.00 |
Technical Indicators
Market Signals| Indicator | MDCX | MMA |
|---|---|---|
| Relative Strength Index (RSI) | 35.19 | 51.86 |
| Support Level | $0.38 | $0.35 |
| Resistance Level | $0.52 | $0.50 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 17.58 | 86.88 |
Price Performance
Historical Comparison MDCX
MMA
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About MMA Alta Global Group Limited
MMA Inc develops technology solutions for the martial arts and combat sports sector. Its platform is designed to support gyms and related businesses by improving areas such as sales channels, customer onboarding, and member engagement. The platform also connects participants, gyms, and communities within the sector, enabling digital management and interaction.